GRIFOLS | GRF - Ebitda

Stock Price
10.93
Daily Change
-0.03 -0.23%
Monthly
-3.27%
Yearly
34.61%
Q1 Forecast
10.50

GRIFOLS reported EUR347.24M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Alcon AG USD 654M 404M Sep/2025
Amadeus IT EUR 652.7M 5M Sep/2025
Amarin USD 12.54M 28.57M Jun/2025
argenx SE USD 288.02M 84.53M Jun/2025
AstraZeneca USD 4.96B 127M Jun/2025
Bayer EUR 1.51B 1.28B Sep/2025
Cie Automotive EUR 345.96M 35.96M Dec/2024
Demant DKK 2.76B 165M Dec/2025
Ence Energia y Celulosa EUR 12.7M 10.8M Sep/2025
Essilor EUR 3.09B 356M Dec/2024
Ferrovial EUR 586M 17M Dec/2024
Fresenius EUR 850M 22M Sep/2025
Fresenius Medical Care EUR 931.26M 60.26M Sep/2025
Galapagos EUR -158.71M 177.84M Mar/2025
Genmab DKK 477M 101M Sep/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Inditex EUR 3.19B 467M Sep/2025
Merck EUR 1.46B 45M Jun/2025
Novartis USD 5.88B 290M Sep/2025
Philips EUR 738M 9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.84B 2.95B Sep/2025
Smith & Nephew USD 796M 139M Dec/2025
UCB EUR 1.03B 334M Jun/2025
Viscofan EUR 73.08M 6.17M Sep/2025